Latest News for PERCF
Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) has received a $700,000 Research and Development Tax Incentive rebate for the 2026 financial year, providing...
Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) (Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF)) remains on track to begin a Phase II trial of HMBD-002 in...
Provaris Energy Ltd (ASX:PV1, OTC:GBBLF, FRA:WS90) made further technical and commercial progress across its compressed hydrogen and liquid carbon dioxide...
American Rare Earths Ltd (ASX:ARR, OTCQX:ARRNF) accelerated development of its flagship Halleck Creek Rare Earths Project during the June 2026 quarter,...
archTIS Ltd (ASX:AR9, OTCQB:ARHLF) closed the June 2026 quarter with annual recurring revenue of $14.8 million, record full-year contracted sales and...
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for PERCF.
Senate Trading
No Senate trades found for PERCF.
U.S. House Trading
No House trades found for PERCF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.